Global Point-of-Care Testing (POCT) Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Apr 2021
  • Global
  • 357 Pages
  • No of Tables: 59
  • No of Figures: 170

Global Point-of-Care Testing (POCT) Market, By Product (Glucose Monitoring, Cardiometabolic Testing, Infectious Disease Testing, Coagulation Testing, Pregnancy and Fertility Testing, Tumor/Cancer Marker Testing, Urinalysis Testing, Cholesterol Testing, Hematology Testing, Drugs-of-Abuse Testing, Fecal Occult Testing), Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), Prescription (OTC Testing, Prescription-based Testing), Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse (DoA) Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing), End-Use (Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Point-of-Care Testing (POCT) Market Market Analysis and Insights : Global Point-of-Care Testing (POCT) Market

The global point-of-care testing (POCT) market is expected to witness market growth at a rate of 9.25% in the forecast period of 2021 to 2028 and is expected to reach USD 49.77 billion by 2028. Data Bridge Market Research report on point-of-care testing (POCT) market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the prevalence of infectious diseases is escalating the growth of point-of-care testing (POCT) market.

Point-of-care testing refers to medical diagnostic testing that is known to be conducted in or around the point of care. It allows medical practitioners to achieve precise, lab-quality and diagnostic results in real-time within minutes.

The rise in funding by multiple sources across the globe acts as one of the major factors driving the growth of point-of-care testing (POCT) market. The increase in the incidences of target diseases and infectious diseases among population such as coronavirus and increase in demand for POC tests due to the divisions such as operating room, cath labs, ICU, emergency room and neonatal intensive care units among others in order to provide effective and rapid patient care accelerate the point-of-care testing (POCT) market growth. The rise in demand for home healthcare encouraging manufacturers to commercialize portable products that are user-friendly and emergence of smartphone-oriented healthcare solutions, digital technologies and embedded vision-based solutions further influence the point-of-care testing (POCT) market. Additionally, rise in significance of POC diagnostics in environmental monitoring and public health, rise in number of CLIA-waived POC tests, increase in technological advancement and surge in healthcare expenditure positively affect the point-of-care testing (POCT) market. Furthermore, growth in provider awareness about novel technologies and rise in demand for POC tests with multiplexing capabilities extend profitable opportunities to the point-of-care testing (POCT) market players in the forecast period of 2021 to 2028.

On the other hand, high cost associated with the products, pricing pressure owing to reimbursement cuts and budget constraints and stringent regulatory policies are the factors expected to obstruct the point-of-care testing (POCT) market growth. Lack of alignment with definitive central lab methods and reluctance to change existing diagnostic practices are projected to challenge the point-of-care testing (POCT) market in the forecast period of 2021-2028.

This global point-of-care testing (POCT) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on point-of-care testing (POCT) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Point-of-Care Testing (POCT) Market Scope and Market Size

The global point-of-care testing (POCT) market is segmented on the basis of product, technology, prescription, application and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

  • On the basis of product, the point-of-care testing (POCT) market is segmented into glucose monitoring, cardiometabolic testing, infectious disease testing, coagulation testing, pregnancy and fertility testing, tumor/cancer marker testing, urinalysis testing, cholesterol testing, hematology testing, drugs-of-abuse testing and fecal occult testing. Cardiometabolic testing is further segmented into cardiac markers, blood gas/electrolytes testing kits, hba1c testing kits and lipids testing. Infectious disease testing is further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections, respiratory infections testing kits and others. Cholesterol testing is further segmented into prothrombin time testing kits and activated clotting time testing kit.
  • On the basis of technology, the point-of-care testing (POCT) market is segmented into lateral flow assays, dipsticks, microfluidics, molecular diagnostics, immunoassays, agglutination assays, flow-through, solid phase and biosensors.
  • On the basis of prescription, the point-of-care testing (POCT) market is segmented into OTC testing and prescription-based testing.
  • On the basis of application, the point-of-care testing (POCT) market is segmented into cardio metabolic testing, infectious disease testing, nephrology testing, drug-of-abuse (DoA) testing, blood glucose testing, pregnancy testing and cancer biomarker testing.

On the basis of end-use, the point-of-care testing (POCT) market is segmented into hospitals, diagnostic centers, research laboratories and home-care settings. Hospitals are further segmented into emergency department critical-care unit, general ward and others. Clinics are further segmented into physicians  clinic and diagnostic clinic.

Global Point-of-Care Testing (POCT) Market Country Level Analysis

The global point-of-care testing (POCT) market is analyzed and market size insights and trends are provided by country, product, technology, prescription, application and end-use as referenced above.      

The countries covered in the point-of-care testing (POCT) market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the point-of-care testing (POCT) market because of the rapidly increasing COVID-19 cases in the U.S. and Canada and rise in the prevalence of infectious diseases. Asia-Pacific is expected to witness the fastest growth during the forecast period of 2021 to 2028 because of the development of healthcare infrastructure, rise in the adoption of miniaturized models and measures and higher prevalence of chronic and targeted diseases in the region.

The country section of the point-of-care testing (POCT) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The global point-of-care testing (POCT) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for point-of-care testing (POCT) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point-of-care testing (POCT) market. The data is available for historic period 2011-2019. 

Competitive Landscape and Point-of-Care Testing (POCT) Market Share Analysis

The global point-of-care testing (POCT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to point-of-care testing (POCT) market.

The major players covered in the point-of-care testing (POCT) market report are Abbott,  F. Hoffmann-La Roche Ltd, Siemens AG, Beckman Coulter, Inc., BD, Johnson & Johnson Services, Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Medtronic, Accriva Diagnostics, Opti Medical, Sienco, Inc., Alpha Scientific Electronics, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics Inc., bioMérieux SA, Biomerica, Inc., Binx Health, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, Nova Biomedical among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Point-of-Care Testing (POCT) Market 

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLE GLOBAL POINT-OF-CARE TESTING MARKET

TABLE 1 LIST OF DIFFERENT TYPES OF APPROVAL FOR DIFFERENT COUNTRIES TABLE 2 GLOBAL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 3 GLOBAL CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 4 GLOBAL INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 5 GLOBAL CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 6 GLOBAL POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 7 DISTRIBUTION CHANNEL, DIRECT TENDER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 8 DISTRIBUTION CHANNEL, RETAIL PHARMACY, BY REGION, 2015 – 2024 (USD MILLION) TABLE 9 GLOBAL POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 10 GLOBAL POINT-OF-CARE TESTING MARKET, HOSPITALS, BY REGION 2015– 2024 (USD MILLION) TABLE 11 GLOBAL POINT-OF-CARE TESTING MARKET, CLINICS, BY REGION 2015– 2024 (USD MILLION) TABLE 12 GLOBAL POINT-OF-CARE TESTING MARKET, AMBULATORY CARE, BY REGION 2015– 2024 (USD MILLION) TABLE 13 GLOBAL POINT-OF-CARE TESTING MARKET, HOME HEALTHCARE, BY REGION 2015– 2024 (USD MILLION) TABLE 14 GLOBAL POINT-OF-CARE TESTING MARKET, RESEARCH LABORATORY, BY REGION 2015– 2024 (USD MILLION) TABLE 15 GLOBAL POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015– 2024 (USD MILLION) TABLE 16 GLOBAL POINT-OF-CARE TESTING MARKET, PRESCRIPTION BASED TESTING KITS, BY REGION, 2015– 2024 (USD MILLION) TABLE 17 GLOBAL POINT-OF-CARE TESTING MARKET, OVER THE COUNTER BASED TESTING KITS, BY REGION, 2015– 2024 (USD MILLION) TABLE 18 GLOBAL POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY, 2015 – 2024 (USD MILLION) TABLE 19 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 20 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 21 NORTH AMERICA CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 22 NORTH AMERICA INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024(USD MILLION) TABLE 23 NORTH AMERICA CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024(USD MILLION) TABLE 24 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE 2015 – 2024 (USD MILLION) TABLE 25 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 26 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 27 U.S.POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 28 U.S. POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 29 U.S. POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 30 U.S. POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 31 CANADA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 32 CANADA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 33 CANADA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 34 CANADA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 35 MEXICO POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 36 MEXICO POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 37 MEXICO POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 38 MEXICO POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 39 EUROPE POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 40 EUROPE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 41 EUROPE CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 42 EUROPE INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 43 EUROPE CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 44 EUROPE POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE 2015 – 2024 (USD MILLION) TABLE 45 EUROPE POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 46 EUROPE POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 47 GERMANY POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 48 GERMANY POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE 2015 – 2024 (USD MILLION) TABLE 49 GERMANY POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 50 GERMANY POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 51 FRANCE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 52 FRANCE POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE , 2015 – 2024 (USD MILLION) TABLE 53 FRANCE POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 54 FRANCE POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 55 U.K. POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 56 U.K. POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 57 U.K. POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 58 U.K. POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 59 ITALY POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 60 ITALY POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 61 ITALY POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 62 ITALY POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 63 SPAIN POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 64 SPAIN POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 65 SPAIN POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 66 SPAIN POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 67 RUSSIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 68 RUSSIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 69 RUSSIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 70 RUSSIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 71 TURKEY POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 72 TURKEY POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 73 TURKEY POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 74 TURKEY POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 75 BELGIUM POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 76 BELGIUM POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 77 BELGIUM POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 78 BELGIUM POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 79 NETHERLANDS POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 80 NETHERLANDS POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 81 NETHERLANDS POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 82 NETHERLANDS POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 83 SWITZERLAND POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 84 SWITZERLAND POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 85 SWITZERLAND POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 86 SWITZERLAND POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015–2024 (USD MILLION) TABLE 87 REST OF EUROPE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 88 APAC POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 89 APAC POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 90 APAC CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 91 APAC INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 92 APAC CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 93 APAC POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 94 APAC POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 95 APAC POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL , 2015– 2024 (USD MILLION) TABLE 96 JAPAN POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 97 JAPAN POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE , 2015 – 2024 (USD MILLION) TABLE 98 JAPAN POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 99 JAPAN POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 100 CHINA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 101 CHINA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE , 2015 – 2024 (USD MILLION) TABLE 102 CHINA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 103 CHINA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 104 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 105 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 106 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 107 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 108 INDIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 109 INDIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 110 INDIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 111 INDIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL , 2015– 2024 (USD MILLION) TABLE 112 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 113 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 114 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 115 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 116 SINGAPORE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 117 SINGAPORE POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 118 SINGAPORE POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 119 SINGAPORE POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 120 THAILAND POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 121 THAILAND POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 122 THAILAND POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 123 THAILAND POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 124 MALAYSIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 125 MALAYSIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 126 MALAYSIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 127 MALAYSIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 128 INDONESIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 129 INDONESIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 130 INDONESIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 131 INDONESIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 132 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 133 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 134 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 135 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 136 REST OF APAC POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 137 MEA POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 138 MEA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 139 MEA CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 140 MEA INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE,2015 – 2024 (USD MILLION) TABLE 141 MEA CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 142 MEA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 143 MEA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 144 MEA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 145 SOUTH AFRICA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 146 SOUTH AFRICA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 147 SOUTH AFRICA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 148 SOUTH AFRICA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015–2024 (USD MILLION) TABLE 149 SAUDI ARABIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 150 SAUDI ARABIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 151 SAUDI ARABIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 152 SAUDI ARABIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 153 UAE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 154 UAE POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE , 2015 – 2024 (USD MILLION) TABLE 155 UAE POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 156 UAE POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 157 REST OF MEA POINT-OF-CARE TESTING MARKET, BY PRODUCTTYPE, 2015 – 2024 (USD MILLION) TABLE 158 SOUTH AMERICA: HEALTHCARE SPENDING (USD PER HEAD) TABLE 159 SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY COUNTRY,2015 – 2024 (USD MILLION) TABLE 160 SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 161 SOUTH AMERICA CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 162 SOUTH AMERICA INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024(USD MILLION) TABLE 163 SOUTH AMERICA CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 164 SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 165 SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 166 SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 167 BRAZIL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 168 BRAZIL POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 169 BRAZIL POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 170 BRAZIL POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions